Helius Medical Technologies, Inc. (HSDT)
- Previous Close
0.2917 - Open
0.3100 - Bid --
- Ask --
- Day's Range
0.2854 - 0.3100 - 52 Week Range
0.2600 - 4.2000 - Volume
73,745 - Avg. Volume
134,586 - Market Cap (intraday)
1.834M - Beta (5Y Monthly) 1.28
- PE Ratio (TTM)
-- - EPS (TTM)
-4.3300 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
heliusmedical.comRecent News: HSDT
View MorePerformance Overview: HSDT
Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSDT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSDT
View MoreValuation Measures
Market Cap
1.83M
Enterprise Value
757.74k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.56
Price/Book (mrq)
1.73
Enterprise Value/Revenue
1.46
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-154.25%
Return on Equity (ttm)
-688.88%
Revenue (ttm)
520k
Net Income Avi to Common (ttm)
-11.74M
Diluted EPS (ttm)
-4.3300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.09M
Total Debt/Equity (mrq)
1.13%
Levered Free Cash Flow (ttm)
-5.86M